PharmiWeb.com - Global Pharma News & Resources
31-Jan-2019

Acute Coronary Syndrome - Pipeline Insight, 2019 - ResearchAndMarkets.com

The "Acute Coronary Syndrome - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Acute Coronary Syndrome - Pipeline Insight, 2019 offers a comprehensive insight of the pipeline (under development) therapeutics scenario and growth prospects across Acute Coronary Syndrome development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Scope

  • The report provides a snapshot of the pipeline development for the Acute Coronary Syndrome
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Acute Coronary Syndrome
  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Acute Coronary Syndrome
  • The report also covers the dormant and discontinued pipeline projects related to Acute Coronary Syndrome

Topics Covered

1. Report Introduction

2. Acute Coronary Syndrome Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Acute Coronary Syndrome

4. Comparative Analysis

5. Products in Clinical Stage

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

  • Product Description
  • Research and Development
  • Product Development Activities

Companies Featured

  • AdvanceCor GmbH
  • Arena Pharmaceuticals Inc.
  • Ascendia Pharmaceuticals LLC
  • Athera Biotechnologies AB
  • Bayer AG
  • Cardiome Pharma Corp.
  • Cerenis Therapeutics Holding SA
  • CSL Limited
  • Esperion Therapeutics Inc.
  • HitGen Ltd.
  • Japan Tobacco Inc.
  • Lee's Pharmaceutical Holdings Limited

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/5k6f3j/acute_coronary?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190131005806/en/

Editor Details

Last Updated: 31-Jan-2019